A well-crafted narrative helps investors see not just the molecule in front of them, but the broader therapeutic and ...

A Bay Area biotech company is behind a potentially groundbreaking blood test that promises to be a game-changer in cancer ...

After Intellia Therapeutics paused a pair of phase 3 trials for its CRISPR therapy in response to a liver safety signal, the ...

The Swiss pharma is paying $12 billion for Avidity Biosciences and its three late-stage antibody oligonucleotide conjugates.

Still, the recently released 2025-30 Arizona Bioscience Roadmap, as well as several academic, community and local government ...

The Food and Agriculture Organisation of the United Nations (FAO) spoke to us at Future Food-Tech about how innovation can ...

As Labiotech attented the NLS Days this week, it was the occasion to learn more about the biotech industry in Sweden.

It is evolutionarily certain that we will have more outbreaks, more pandemics, and frankly, they could be significantly worse ...

When members of the Baldwin High School Class of 1983 held their 30-year reunion, Doug Strott declined to attend. “I was ...

Licensing remains a dominant model. The value of the licensing-out deals signed by Chinese biotech firms in the first half of ...

Drug giants Novo Nordisk and Pfizer are locked in a fierce $9 billion bidding war for obesity drug developer Metsera. Novo's ...

The California Collaborative for Educational Excellence is launching a pilot program to redesign high school and middle school. Groups of districts applied for grant money, and winners will ...